Inimmune Expands Leadership Team to Propel Allergy Treatment Programs Forward Inimmune Corporation has announced key appointments in its leadership team, including a new Chief Medical Officer and Head of Financial Strategy, aligning their growth strategies for upcoming clinical milestones.

Inimmune Expands Leadership Team to Propel Allergy Treatment Programs Forward #United_States #Immunotherapy #Missoula #Allergy_Treatment #Inimmune

Inimmune Launches Critical Phase 2 Trial for Allergy Treatment INI-2004 Inimmune Corporation has initiated its Phase 2 clinical trial to evaluate INI-2004 for allergic rhinitis, aiming to provide new lasting relief for patients.

Inimmune Launches Critical Phase 2 Trial for Allergy Treatment INI-2004 #Canada #Kingston #Allergic_Rhinitis #INI-2004 #Inimmune